Publication | Closed Access
Simeprevir (TMC435) with Peginterferon/Ribavirin for treatment of chronic HCV genotype 1 infection in treatment-naïve european patients in the quest-1 and quest-2 phase III trials
30
Citations
0
References
2014
Year
Viral HepatitisAntiviral Drug DevelopmentAntiviral TherapyHepatitisVirologyChronic Viral InfectionAntiviral DrugMedicineTreatment-naïve European Patients
No additional data available for this publication yet. Check back later!